![Agios Pharmaceuticals Inc](/common/images/company/N_AGIO.png)
Agios Pharmaceuticals Inc is a biopharmaceutical company with a focus on developing treatments geared towards cancer and rare genetic disorders of metabolism. The company's primary focus is to develop potentially transformative small-molecule medicines. The clinical development strategy for Agios' p... Agios Pharmaceuticals Inc is a biopharmaceutical company with a focus on developing treatments geared towards cancer and rare genetic disorders of metabolism. The company's primary focus is to develop potentially transformative small-molecule medicines. The clinical development strategy for Agios' product candidates includes a precision approach with initial study designs that allow for genetically or biomarker-defined patient populations. The company seeks the potential for proof of concept early in clinical development, along with any potential for accelerated approval. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.98 | -2.91319857313 | 33.64 | 35.09 | 32.38 | 689603 | 34.01446516 | CS |
4 | -1.95 | -5.63420976596 | 34.61 | 35.84 | 31.3863 | 636561 | 33.58969864 | CS |
12 | -19.7 | -37.6241405653 | 52.36 | 62.45 | 31.3863 | 861285 | 40.13031658 | CS |
26 | -11.07 | -25.3144294535 | 43.73 | 62.58 | 31.3863 | 682901 | 43.50855003 | CS |
52 | 7.39 | 29.2441630392 | 25.27 | 62.58 | 24.69 | 721730 | 39.84605021 | CS |
156 | 1.56 | 5.01607717042 | 31.1 | 62.58 | 16.75 | 623539 | 30.93793492 | CS |
260 | -16.3 | -33.2924836601 | 48.96 | 62.58 | 16.75 | 644387 | 36.91565636 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.